3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
17
Phase 4
3
Phase 1
2
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Completed
16
Unknown
4
Terminated
3
Recruiting
3
Withdrawn
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Breast Neoplasms
33
Neoplasms
16
Prostatic Neoplasms
15
Lung Neoplasms
11
Carcinoma, Hepatocellular
11
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Papillomavirus Infections
6
Pain, Postoperative
6
Neoplasm Metastasis
6
Liver Neoplasms
6
Leukemia, Myeloid, Acute
6
Stomach Neoplasms
5
Recurrence
5
Lymphoma, Non-Hodgkin
4
Kidney Neoplasms
4
Heart Failure
4
Glioma
4
Febrile Neutropenia
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Warts
3
Vomiting
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Interventions
Polyethylene Glycols
1
Oxycodone
1
Magnesium Hydroxide
1
Fentanyl
1
Electrolytes
1
Dosage Forms
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Cancer Pain
×
Clear all
NCT07001709
2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4
Recruiting
29 enrolled
NCT05216328
2024-11-22
OMAMA
Amsterdam UMC, location VUmc
Phase 4
Recruiting
330 enrolled
NCT06498037
2024-07-12
FERRARI
Erasmus Medical Center
Phase 4
Recruiting
45 enrolled